Fidelity Investments
MIRM icon

Fidelity Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Fidelity Investments’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430M Buy
3,670,314
+1,704,939
+87% +$171M 0.02% 614
2026
Q1 		$182M Buy
1,965,375
+1,318,909
+204% +$124M 0.01% 906
2025
Q4 		$51.1M Buy
646,466
+6,248
+1% +$448K ﹤0.01% 1440
2025
Q3 		$46.9M Buy
640,218
+580,777
+977% +$36.9M ﹤0.01% 1457
2025
Q2 		$3.02M Buy
59,441
+5,114
+9% +$228K ﹤0.01% 2341
2025
Q1 		$2.45M Buy
54,327
+49,512
+1,028% +$2.33M ﹤0.01% 2382
2024
Q4 		$199K Buy
4,815
+3,498
+266% +$146K ﹤0.01% 3269
2024
Q3 		$51.4K Buy
1,317
+431
+49% +$17.2K ﹤0.01% 3773
2024
Q2 		$30.3K Sell
886
-19,435
-96% -$510K ﹤0.01% 3870
2024
Q1 		$510K Sell
20,321
-456
-2% -$12.5K ﹤0.01% 2710
2023
Q4 		$613K Buy
20,777
+19,204
+1,221% +$581K ﹤0.01% 2616
2023
Q3 		$49.7K Sell
1,573
-2,169
-58% -$59.4K ﹤0.01% 3371
2023
Q2 		$96.8K Buy
3,742
+2,723
+267% +$72.4K ﹤0.01% 3175
2023
Q1 		$24.5K Buy
1,019
+292
+40% +$6.66K ﹤0.01% 3760
2022
Q4 		$14.2K Buy
727
+52
+8% +$1.03K ﹤0.01% 3895
2022
Q3 		$14K Buy
675
+107
+19% +$2.58K ﹤0.01% 3970
2022
Q2 		$11K Sell
568
-82
-13% -$1.93K ﹤0.01% 4090
2022
Q1 		$14K Buy
+650
New +$13.3K ﹤0.01% 4132
2021
Q3 		– Sell
-114,328
Closed -$1.98M – 4766
2021
Q2 		$1.98M Hold
114,328
– – ﹤0.01% 2552
2021
Q1 		$2.27M Sell
114,328
-44,900
-28% -$860K ﹤0.01% 2446
2020
Q4 		$2.78M Sell
159,228
-54,336
-25% -$1.07M ﹤0.01% 2326
2020
Q3 		$4.12M Sell
213,564
-21,436
-9% -$460K ﹤0.01% 2126
2020
Q2 		$4.57M Hold
235,000
– – ﹤0.01% 2079
2020
Q1 		$3.29M Buy
+235,000
New +$3.86M ﹤0.01% 2059

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments's MIRM Position: Q2 2026 in Review

Fidelity Investments increased its Mirum Pharmaceuticals (MIRM) stake by 87% in Q2 2026, buying an estimated $171M and bringing the position to 3,670,314 shares worth $430M. The position accounts for 0.02% of the portfolio, ranked #614.

Fidelity Investments first reported a position in MIRM in Q1 2020 and has held it in 24 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Fidelity Investments held 3,670,314 shares of Mirum Pharmaceuticals worth $430M as of Q2 2026.
  • Fidelity Investments bought 1,704,939 Mirum Pharmaceuticals shares in Q2 2026, an estimated $171M.
  • Mirum Pharmaceuticals made up 0.02% of Fidelity Investments's portfolio in Q2 2026, its #614 holding.
  • Fidelity Investments first reported a position in Mirum Pharmaceuticals in Q1 2020 and has held it in 24 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.